Dimethyl Fumarate is an immunomodulatory and anti-inflammatory agent used in the treatment of relapsing forms of multiple sclerosis (MS) and psoriasis. It activates the Nrf2 pathway, providing neuroprotective and anti-inflammatory effects. Dimethyl Fumarate API is produced under GMP standards and is suitable for oral solid dosage forms, including capsules and tablets.

Dimethyl Fumarate API is manufactured and supplied by ASTANDARDS | Artis Biotech, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.